CDC: All baby boomers should get hepatitis C test
CMS innovation center awards 26 grants worth $122.6M
Patients responsible for 26% of health bills in 2011 vs 21% in '09
PwC: Pharma comes up short convincing payers of cost efficacy
Senate could vote next week to give FDA broader regs authority
Supercomputers make biopharma a super investment
Delhi's drug regs OD: focus should be on real problem, fake meds
Domestic pharmas join critics of India's drug price cap proposals
Euro RSCG: I used to say 95% of all advertising is crap. It still is..
Four ways to make medicine (pay) more like Facebook
Health care consolidation and competition after PPACA
Looking back at two years of social media in health care
McKinsey: 5 questions to ask to measure marketing's worth
NIH ID's 40 approved drugs showing promise for rare bone Ca
PhRMA: World trying to lure biopharmaceutical R&D from US
White House issues statement of support for PDUFA bill
Cancer Genetics postpones $48M IPO amid Facebook frenzy
GSK relations w/ 3 cos show one deal can lead to another, or not
Intel: Teen wins fair w/ early stage, noninv pancreatic Ca test
PDR & iHealth drug safety certification program for EHRs & e-Rxs
Pfizer recalls Advil Liqui-Gel over concerns of unusual odor
Polymathism is largely untapped force in business practice
Silence & Alnylam updates on RNAi candidates for solid Ca's
Spectral Diagnostics opens toraymyxin Ph 3 to cut sepsis death
There are ways plans can curtail copay coupons' use
Ventricular 'parachute' has big impact on HF outcomes
$16M of new NIH 2012 Alzheimers $50M to Roche in Columbia
Accelerating gene driven dis is due to "weak purifying selection"
Accelerating part 2: Rare mutations cause dis, complicate R&D
AMA: How external pressures affect physicians' prescribing
BG Med files for expanded indication of Galectin-3 test in HF
Biogen, Elan: Greatest increase in Tysabri PML risk after two yrs
Bioquell to benefit from risks of cross-contamination in bio-mfrg
Canada OK's Osiris' Prochymal. 1st stem cell Tx for systemic dis
Drugmakers weigh emergency supply plan for Greece
GSK's top North American exec dips toe into blogosphere
Kleiner Perkins backs early-stage biotechs with $525M fund
Mutations in STAT3 are common in LGLL suggesting causation
No scientific evidence suggests we use only 10% of our brains
Shareholder spring is offering even more sport than usual
Yale: US approves drugs faster than Europe and Canada
Allergan to build R&D plant, add 400 jobs in New Jersey
Antibiotics still beat probiotics at preventing UTIs
Avraham opens Ph 2 for ladostigil in mild cognitive impairment
Cataloging wounds of war in Afghanistan to help heal them
CDC's 1999-2008 US Cancer Statistics (USCS) released
Could GSK's BRAF inh top combo Roche's Zelboraf in melanoma?
Coventry ends deal to cover Sequenom's Down Syndrome test
Doubt cast on the 'good' in 'good cholesterol'
Fall River, MA breaks ground on Biomanufacturing Accelerator
Fate of 'uninsurables' hinges on Supreme Court
New Hampshire approves bill for tracking Rx drug abuse
Percentage of girls completing all 3 doses of HPV vax dropping
Stopping fake drugs in Pakistan too late for victims
There's an elephant in LR: R&D cuts akin to eating seed corn
VC model: "We vave met the enemy... and he is us"
5 processes cause breast Ca mutations; One, a 'sudden storm'
Aargh!! J$J recalls continue with Imodium OTC antidiarrheal
At 2 years old, she's already a chemo survivor & medical pioneer
Broad Inst: Raising HDL of little benefit. CETP's coupe de grace?
CETP discoverer hangs on to glimmer of hope
How did child psychiatry become 'ped psychopharmacology'?
Human Genome adopts poison pill with 15% trigger to fight GSK
Human Genome Sciences claims talks with other "major" cos
Pfizer ALK blkr, Xalkori: "Really extraordinary" in COG study
Plavix expiry will be brutal. Multiple generic entries
Plavix expiry won't help Lilly, AstraZeneca with Effient, Brilinta
Rosetta Genomics gets 1st Medicare coverage of microRNA Dx
SEC probes Dendreon amid shareholder lawsuits
Agilent to buy Dako diagnostics for $2.2B in its biggest ever deal
Belt & suspenders approach needed to manage IP risk in China
CoverMyMeds plugs in to NaviNet's communications network
Credibility vs Control: Core difference between PR & advertising
Driver mutations advantage to breast Ca cells for oncogenesis
Elsevier editor resigns: Can't put profits over research access
Is Morgan Stanley's ReachOut Health abusing kids, soaking US?
Lancet: NHS 'should consider giving statins to healthy people'
Pfizer, GSK, J&J grab ASCO spotlight targeting Ca genetics
Physicians are often unfamiliar with long-term risks of chemo
Sales forces shrank in 2011, but not everywhere
Ambit & Teva get FDA IND for BRAF (V600E) inh, CEP-32496
ArQule, Daiichi Sankyo's tivantinib wins in c-Met liver Ca Ph 2
Auxilium says new patent protects Testim gel to 2023
Dendreon's Provenge works best for patients with low PSA
J&J's Zytiga can eliminate high-risk prostate Ca if given early
Kythera Bio files plans for IPO of $86.3M to advance ATX-101
No industry despises IT (accountability) as much as health care
Novartis' NVA237 superior to placebo over 1 year in COPD
Popular antibiotic, azithromycin, may raise sudden death risk
Republicans to publicize pharma industry's Obamacare deal
Roche's Zelboraf cuts 12 mon melanoma death risk by 38%
Tolerability of Aveo/Astellas' tivozanib impresses in kidney Ca
Array shares rise on lung Ca, melanoma data for selumetinib
ASCO 2012 abstract data dump: Cancer stocks in focus
Computer Sciences posts loss due to UK NHS HIT contract
EU Parliament seeks urgent review of drug monitoring
Express Scripts to settle charges over controlled drug thefts
FCC chooses spectrum for wireless medical devices
FDA warning on NJ mfrg plant hurts Hikma margins on generics
House panel's 'classic pursuit' of Pfizer, PhRMA execs on 'the deal'
J&J "very serious" about acquiring CNS & Ca assets in China
Pharmageddon continues: Plavix exclusivity ends Thursday
Piramal gets Manhattan Research in $365M Dec Resources buy
Targeted Ca drugs with punch: The next big class of antibodies
Alliance Boots defends taxes paid; Eyes M&A exit strategy
Amgen revives rilotumumab on data for high c-Met gastric Ca
Basics of biz: With risk-shift, providers face collection challenges
Complex universe of patent litigation: "Sport of kings"
Consumer Reports: Long-term benefit of ADHD drugs uncertain
Embedded chips, GPS pacemakers.. what's in our health future?
FDA reviews drugs quite quickly, thank you
GSK's dabrafenib/trametinib cocktail slows melanoma w/ less tox
Money, matrices & analytics: Why ACOs may be different
Pfizer's Torisel can't beat Bayer's Nexavar in renal cell Ca
Shareholder proposals for lobbying disclosure fail @ WellPoint
US PEPFAR HIV aid has prevented 741K Africa deaths @ $27 per
50-nation, Global Research Council announced after NSF mtg
Abbott's Xience wins shortest duration of anti-platelet Tx, 3 mos
Almost divine intervention: Robotic limbs controlled by thoughts
Are arrogant docs & scary regs keeping techies out of health?
Big data analytics coming to life sciences; But they're not here yet
Biotech career progression opportunities much different today
Cardinal DEA deal calls for 2-yr controlled drug shipping halt
China FDA approves Baxter's Advate, Factor VIII in hemophilia
Copyright decision favors nonprofit institutions vs publishers
Court to hear appeal of dismissal of PA Risperdal suit v. J&J
Critics say fed agency should oversee DSM's shilling for pharma
Data-mining in doctor's office helps solve medical mysteries
Early signs of Parkinson's alpha-synuclein may be seen in colon
Elavation: EP-101's Ph 2b, new nebulizer 'gold standard' in COPD
Endo leads pharma's revived interest in device combination devt
Ex-BMS exec ordered by judge to write a book... is finished
FDA panel backs OraSure's in-home HIV test; Retail under $60
GE's 2 & 1/2 year-old, $250M VC fund still has 'lot of dry powder'
Genes are overrated, genetics is underrated
Get what u pay for: UK drug shortages arise from parallel trade
GSK buys remaining 80% of Cellzome, proteomics tech for $98M
HHS launches national trend, health indicator comparison tool
Hmmm.. SAC Cap bought 1.2M Ardea shrs before $1.3B AZ buy
If there are no standards for peer review, what's it worth?
International groups push patent pool to solve funding problems
Last lecturer's spouse: "Dream New Dreams... a new life"
Lessons from the front line of health care delivery reform
Mayo: 10 recs to close credibility gap in medical research
Mgd care will req multi-TNF failures before Pfizer's tofacitinib
Mobile app focuses on better patient 'handoffs' to cut errors
Mologen's MGN1703 extends PFS twofold in colorectal Ca
Nanofluid device detects, sorts molecules by epigenetic state
New drug trial seeks to stop Alzheimer's before it starts
NICE u-turns to fund Zytiga in prostate Ca after J&J discounts
No options? Ahead of IPO, GM to quit advertising on Facebook
Northwest Bio's DCVax doubles survival time in glioblastoma
Pfizer, BMS, Merck, Sanofi, Takeda, Roche & AZ bid for Amylin
Piramal to buy Decision Resources for about $635M
Prolor nets $35M in public offering for long-acting biobetters
Promedior's Shire vet CEO takes its $22M from Philly to Boston
Ra Pharma gets $8.6M; Unveils HAE as lead for cyclomimetics
Roche seeks to show its pipeline can protect oncology franchise
Roche's crenezumab picked for asymptomatic Alzheimer's trial
UK's NICE delays access to new cancer drugs for years
US biosimilars law is 2 yrs old & FDA has yet to receive an app
WHO warns of HTN, diabetes, obesity spread to poor nations
$1 Trillion in revenue at stake for insurers in SCOTUS' ACA ruling
A brief history of Pfizer's JAK inhibitor, tofacitinib
Achillion's mid-stage ACH-3102 gets FDA fast track in hep C
ADHD behavioral therapy may be more effective than drugs
Agencies going after Accenture, Deloitte's IT, CRM biz
Alzheimers.gov: US launches Alzheimer's plan & research push
AstraZeneca antitrust fine should stand, says EU court aide
AstraZeneca slashes 400 more jobs in Sweden
Can whole genome sequencing contribute to clinical care?
Cardinal facility suspended under DEA settlement
Change.org petition demands US price cut for Novartis' Gleevec
Cornerstone acquires EKR Therapeutics, acute-care hosp prods
Digital health oversold: Pills still matter and so does biology
Drugmakers choose faster trial recruiting over CRO cost cuts
Ex-Accenture exec: Microsoft Windows anology for pharma woes
FDA again cautions on Novartis' Gilenya, the only oral MS drug
FDA, saccharin, me and maybe the mafia - A true story
Financial incentives for feeding tubes lead to dementia in elderly
Five questions for E&Y's exec on the future of health IT
Florida pill mill doctor: "I was driven by greed"
Health insurance expansion heats up primary care turf battle
Hospira hydromorphone recall due to overfill volume issue
Locating American mfrg: Trends in geography of production
Lundbeck's data support Lu AA21004 depression filing in 2012
Mixed reviews, reservations abound for FDA Rx-to-OTC proposal
Private equity firms buy half of Italian generic mfr, Rottapharm
Rising opioid addiction is a problem that can be solved
St Jude gets EU approval for HTN device; Tiny renal nerve scars
St Jude hopes slow & steady wins renal denervation race in HTN
The Atlantic: Mortal struggles; the making of a cancer doctor
Towers pays $435M for #1 US Medicare exchange, Extend Health
UK lawmakers urge action on medicine shortages
Arena & Eisai broaden mktg deal for Lorquess in weight-loss
ASCO preview: 8 cancer drugs to watch at the big show
ASCO: 7 Cancer drug stocks to know right now
Athersys-Pfizer to wrap up IBD Ph 2 for MultiStem drug in 2012
Beat odds at judging risk with fast, clear feedback -Like weather
BioAlliance starts Ph 3 for Livatag in primary liver Ca
Cardinal Health to buy Chicago distributor, Dik Drug
Employers still shifting more of all health costs to workers
Even for Stanford geneticist, applying gene sequencing is tough
Ex-pharma CEO finds success @ very different Smith & Nephew
FDA concept would mean fewer prescriptions, more OTCs
FDA eases biologic sterility test reqs to back state-of-art analyses
FDA grants fast track for Ohr's squalamine drops in wet-AMD
FDA puts new limits on Novartis Gilenya on addl 1st dose death
Furiex: J&J returns global rights to Priligy in premature ejac
Good world health data rare; Extrapolation brings danger
GSK gets FDA approval for acne treatment, Fabior Foam
Marken considers shipping trial drugs direct to patient homes
Maxygen earns $30M from Bayer for recombinant factor VIIa
Meddik: Docs have clinical knowledge; pats, practical knowledge
Nanoparticles deliver high doses of antibiotics directly to bacteria
No better example of industry influence than opioid epidemic
Novo Nordisk initiates share repurchase program
Ono, Paion win in Ph 2 for ONO-2745/CNS 7056 in general anesthesia
Opko's Alzheimer's blood diagnostic expected launch in 2013
Pharma digital dreamers have forgotten some key principles
Roche applies Ca drug devt skills to Alzheimer's & autism
Sanofi plan for Shantha Biotech gets Indian govt approval
Sanofi workers suspend strike, pending agreement on conditions
Servier & founder on trial for 500 deaths assoc w/ Mediator
Ventrus' diltiazem cream (VEN 307) wins in anal fissures Ph 3
Vertex rises as JP Morgan ups rating on cystic fibrosis drugs
23andMe eliminates subscription model - Single $299 price
2M cases of cancer a year due to H pylori, Hep B&C and/or HPV
5-year study seeks definitive answers on proton beams vs radiation
85% of docs own or use a smartphone for professional purposes
Aastrom's autologous stem cell Tx improves dilated cardiomyopathy
Abbott escapes a long-running GMP consent decree
Abbott faces another battle over Kaletra HIV med in Malaysia
Abbott petitions FDA to deny biosimilar apps for BLA approvals prior to March 23, 2010 enactment of BPCIA
Adderral: It's like taking meth, only this is..prescribed by a doctor,
Alliance Boots gloomy on UK economic outlook
Almost 1 in 3 in US sleepwalk at some point in their lives
Alnylam's RNAi drug ALN-TTR01 cuts serum transthyretin protein levels
AMA not smiling over FTC teeth whitening ruling it contends could impede states' medical practice regs
AMAG Pharma is no longer considering a sale; Shares fall
AmerisourceBergen names new finance chief
Amgen to testify @ FDA biosimilars stakeholder hearing
Amylin attracting M&A queries from AstraZeneca, Pfizer & Sanofi
Animal rights activist's conviction stands for comparing Vasella to Hitler
Anti-vax crew takes toll: Whooping cough epidemic in WA state
Arena news boosts Orexigen, Vivus shares
Arena rockets on FDA panel nod; Orexigen & Vivus up
Arena shares up more than 90% in after-hours trading
Army clinical trials to evaluate antipsychotic use in PTSD
Arno Therapeutics gets EU orphan designation for AR-42 in neurofibromatosis type 2
As US argues over health care, nations embrace global coverage
BASi plans more cost cutting as toxicology testing demand slips
Bayer: Cipla breached patent rights by cutting Nexavar price
Berwick on health spending: 'We have to improve our way out of this'
Big data and public health: Reducing unwarranted services
Big pharma could face new scrutiny in US after India report
Big pharma is outsourcing skills that will be critical in future
Bill Cowher fronts BMS-backed 'Melanoma Exposed' awareness campaign
Bill that would help curb drug shortages headed for vote
Biogen launches two new dosing innovations for once-a-week Avonex in relapsing MS
Biogen submissions for BG-12 in MS accepted by EMA & FDA
Bionor & Eurocine's Vacc-4x, nasal HIV vax is immunogenic
Biotech and other life sciences companies flourish in Vienna
Biotech is about accepting that unit of production is living cell
Burrill: Health care today essentially same as 2000 years ago
Canadian hearing for Chantix class-action suit nears
Cancer Genetics plans to go public with $48M IPO
Cardinal bows to US DEA's fight vs opioid abuse
Cardinal Health set for DEA showdown over pain pill sales
Carecloud helps urgent care centers provide immediate assessment and management of sports injuries
CBER Strategic Plan for Regulatory Science & Research 2012-16
CDC: National ALS Registry collects info to help scientists learn more about ALS
Cell Therapeutics gets conditional marketing auth from European Commission for pixantrone in NHL
Cephalon CEO and R&D chief leave Teva
CHI/BCG: Differences in FDA performance by therapeutic area
CMS adds adv practice nurses, pharmacists to 'medical staff'
Cold-chain services to be $7.6B biz in 2013 & $8.9B in 2016
Contract mfr sees US trend in repatriating device mfrg
Could pre-emptive treatment lead to higher HIV infection rates?
Counterfeit or substandard? The role of regulation and distribution channel in drug safety
Diabetes care in England in a 'state of crisis'
Digital collaboration helps docs counter Sunshine Act flaws
Disincentive: Shouldn't EPO & blood Txs been balanced long ago?
Doctors pressured to write OTC Rxs for HSA reimbursement
Drug makers working on emergency supply plan in Greece
EU Alliance for Access to Safe Meds calls for urgent action to clarify when drugs can be used off-label
EU court blocks L'Oreal's trademarks similar to Allergan's Botox
Express Scripts: 2012 profits could miss Wall Street's target
Express Scripts: Specialty drug costs a major employer worry
Facebook to sell apps through new online hub
False choice between Dem's 'fed-centic' & GOP's 'leave it to states'
FDA adv panel backs Gilead's HIV 'Quad' in HIV too
FDA adv panel backs Gilead's Truvada for HIV prevention
FDA advisers rec approval of Arena's diet drug, lorcaserin
FDA approves BMS' new Orencia biologic mfrg facility in MA
FDA issues final rule on sterility testing of biologics; Many steps eliminated
FDA rule would req new medical imaging devices to include pediatric dose settings & instructions
FDA tackles 'public health implications' of in-home HIV test
FDA warns Acorda over averse event reporting
FDA warns MS patients on risky, unproven CCSVI angioplasty
Fed appeals court upholds $21.6M NH verdict v. Mutual Pharma
Federal investigators urge stronger oversight of Medicare Part D
Ferring's Lysteda reduces heavy menstrual flow
Fibrocell raises $3M for personalized cell therapy wrinkle treatments
Fibrocell submits Ph 2 protocol for azficel-T in restrictive burn
FINRA warns of nutraceutical "pump and dump" scams
Forbes: The rebates that ate AZ - Secret world of drug rebates
Francis Collins 'supersizes' obesity documentary on Colbert
Fresenius plans to raise $1.3B to fund Rhoen Klinikum purchase
FTC & Skechers settle toning shoe claims case for $40M
Galectin opens Ph 1/2 for GM-CT-01 & vax combo in melanoma
GenDX gets non-exclusive global rights to distribute Qiagen's LongRange PCR kit
Gene therapy helps children paralyzed by AADC, brain disease
Generic drug labeling carve-out citizen petition scorecard
Generic Lipitor could eventually save NHS a whopping $566M/year
Germany's IQWiG backs BMS' Yervoy for melanoma
Giffen Solutions app, created by fed-up doc, connects MDs and patients
Gilead's crucial AIDS "Quad" pill gets thumbs up
GLP-1s may yet be 21st century's top development in diabetes
GM to stop advertising on Facebook; Paid ads have little impact
Goldman Sachs upgrades Incyte on Jakafi, pipeline and M&A
Google's Sergey Brin making progress in Parkinson's quest
GSK lifts its Theravance stake to 26.7%
GSK needs to add just a little bit more to Human Genome bid
GSK says it received India trials waiver for ambrisentan in PAH
Harvard Alzheimer's research scientific fraud case set for trial
Health plans don't always play hardball with providers
HHS moves to streamline reporting, update e-prescribing reqs
HHS' National Plan to Address Alzheimer's Disease
Humira on solid ground, analysts say, despite Pfizer's JAK
I love my job - I run FDA's China Office - How do you engage a regs counterpart that has export promotion as a primary mission?
IDRI, Aeras team up to develop tuberculosis vaccine
If ACA didn't include exchanges, there'd be more up & running
Improving market analyses with social strategy at 3M
India vows reforms after probe slams approval process
Indian minister complains of anti-generics smear campaign
Inovio's universal avian flu vax generates protective antibodies vs 6 H5N1 viruses in Ph 1
Iressa overreaction? 65% of AZ's pipeline is personalized med
Irish universities lead statin trials for lung failure
Is GSK more interested in HGSI's darapladib than it's letting on?
Is this patient privacy crusader doing more harm than good?
J&J and Medtronic M&A strategies contrast. Can both win?
JAMA: Two sets of experts, two opinions on statins in primary prevention
Juventas recruiting Ph 2a for regenerative JVS-100 in critical limb ischemia
Kaiser: Wide variance in Medicare hosp bills, even in same city
Korean drugmakers jostle for generic Viagra market
Lap Band surgery center owners accused of ID theft, false billing
Lethal problem with St Jude heart device could be widespread
Lilly and Abbott win sales rep overtime case
Lilly shifts spotlight to diabetes pipeline
Lilly: Forget Alzheimer's; think diabetes
Main driver for seeking online health information is privacy
Many psychs believe DSM-5 revisions should be shelved for year
McMaster study: Cardiac ablation more effective than afib drugs
Medco wins CBI's 11th annual Forum on Patient Adherence for pharmacist counseling?
Medecins Sans Frontieres: "Key challenges...glossed over" in vax initiative
Medgenics gets FDA OK for Ph 2b of Epodure in dialysis anemia
Medical boards' actions against docs up 6.8% in 2011
Medical Publishing Insights and Practices Initiative: Restoring credibility of industry-sponsored clinical research
Merck isn't liable for Vioxx heart risks says Australia's top court
Merck KGgA committed to big cost cutting as profits fall
Merck Serono workers threaten to strike over layoffs
Moody's: Non-profit US hospitals to do more with less
More than a third of prescriptions now electronic
Most genetic variations rare, recent, make drug discovery tough
MultiCell: Preclinical data supports MCT-465 & MCT-485 in primary liver Ca
Mylan launches generic Lipitor in France, UK
Nasal steroids not much help in acute sinusitis
NEJM: Consider risks, benefits of long-term bisphosphonate use
Nephromics grants pre-eclampsia assay rights to Thermo Fisher
New Zealand drugmakers deny plans to undermine Pharmac
Newron wins in safinamide Ph 3 for Parkinson's; Signs deal with Zambon
NicOx rises on 1Q12 financials for the first quarter and revealed plans for more ophthalmology acquisitions
NIH: Celgene's Revlimid lengthens myeloma PFS at cost of 2x risk of second Ca's
No DDMAC for new cholesterol Android app
No surprise: Patients are bottleneck in healthcare IT
Not retiring at 65: Physician goes from anti-EHR to pro-ACO
NovaDigm's looks to take single antigen vax vs fungal & bacterial infection to Ph 2
Novartis launches Hecoria, branded generic for Astellas' Prograf
Novartis to probe Indian drug approval allegations
Novartis: Our people prefer internal courses to business schools
Novartis: Pasireotide beats Sandostatin in achromegaly
NuMe focuses on good gut bacteria to help prevent T2D
Nurse practitioners say TX should cut unneeded limits on Rx powers
OIG uncovers flaws in CMS processes, programs
Omnicare settles DoJ controlled substance probe for $50M
OncoMed Pharma files for $115M IPO for Ca mABs
Onconova raises $7M for Rigosertib in myelodysplastic syndromes
OR Health & Science Univ breed mouse model of ADHD
Over 2600 pharmacies have suspicious/excessive CMS billing
PA judges hear arguments in Risperdal case
Patients having St Jude defibrillators removed just in case
Pfizer cuts 50 jobs at Canadian estrogen facility
Pfizer distribution policy criticized by Australian wholesaler
Pfizer to eliminate its defined benefit pension plan
Pfizer's Quigley unit to continue its 8-year asbestos bankruptcy
Pharma, device firms kill CoI rule, win accelerated approval
Plaintiffs hardly ever win malpractice cases going to jury
PolyMedix ends trials for PMX-60056 in anticoagulant reversal
Preclinical services firm, SNBL claims to have fixed troubled facility
PREX2 gene frequently mutated & functional in melanomas
Progress made on Medicare's perpetual 'doc fix'
Promedior moves fibrosis pipeline to Boston; Hires Shire vet as CEO
Propofol: The economics of a generic injectable supply problem
Protesting scientists deliver coffin to Downing Street
Public Citizen: Ranking of State Medical Boards on doc discipline
Pulmotect wins $7.1M to advance PUL-042 against chemo infection
Reimbursement support services will be critical for biosimilars
Relatively passive approach to drug benefit continues in Canada
ReNeuron on track for Ph 2 of ReN001 in disabled stroke patients "during the course of next year"
Researchers duel over Chantix and heart risks
Retail health clinics grow in popularity
Rib-X Pharma postpones IPO after cutting price by 50%
Ropack expands solid dose contract packaging services facility
Rosetta Genomics to raise $2.2M for mRNA molecular assays
Science vs PR: How work is turned into patently junk science
Scottish Med Consortium approves Pfizer's Xiaflex on NHS for Dupuytren's
Silence posts Ph 1 data for Atu027 in neuroendocrine cancers
South Korea: Chinese-made 'health' pills contain human remains
Suppression of creativity in academic labs squelches innovation
Symphony Tech, private equity firm acquires the Wolters Kluwer health analytics biz
Takeda falls most in 14 mos on 40% profit forecast drop
Takeda investing in Juventas' next regenerative med round
Takeda looking for BRIC growth: FY12-14 Mid-Range Plan
Takeda: Vedolizumab spurs resistant Chron's remission in Ph 3
Taxing times for French pharma under radical health reforms
The new study buddy: Adderall, Ritalin, Dexadrine, Concerta and the like
Topotarget posts Ph 1 data on belinostat in thymic carcinoma
UK's MHRA faces 'serious lessons' from PIP scandal
UK's NICE backs Allergan's Botox for some migraine pats
UK's pharma trade group may restrict samples
USDA asks MRI Research to rework enclosures after animal death
Variants linked to disease risk in some groups won't explain it in others
Venter: "We have 200T cells and the outcome of each of them is almost 100% genetically determined"
Watson appoints McKinsey consultant to oversee Actavis acquisition
Watson confirms challenge of Shire's patent for Lialda
Watson confirms patent challenge to Warner Chilcott's Lo Loestrin Fe
Watson to become 3rd-largest generics company with Actavis buy
Web analytics tool organizes diabetics' activity, diet & GLU data
What is Medicare 'double counting' and why are budget experts fighting over it?
Why science is better when it's multinational - Cultural diversity
Will CETP inhibitors, Merck's anacetrapib or Lilly's evacetrapib, survive
Witty targets HGS with first hostile bid
WSJ Reader Consult: To approve or not to approve lorcaserin?
When the 'offshored' analytics are in and the best scientific 'pitch' has been heard... Call TSM to check "the deal's" true fit in BioPharma's eminent "7 P's"
Call John D Waddell, RPh @ +1-610-952-1871
